Assessment of Early Life PFAS Exposure in Perinatal Biospecimens, Infant Formula, and Breastmilk.
围产期生物样本、婴儿配方奶粉和母乳中生命早期 PFAS 暴露的评估。
基本信息
- 批准号:10723660
- 负责人:
- 金额:$ 15.89万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-09-01 至 2026-08-31
- 项目状态:未结题
- 来源:
- 关键词:Active LearningAddressAnalytical ChemistryBehaviorBiologicalBiological MonitoringBiometryBlood specimenBody BurdenBreast FeedingChemical ExposureChemicalsChild HealthChildhoodCommunicationConsumptionDataData AnalysesDeveloped CountriesDevelopmentEnvironmentEnvironmental Engineering technologyEpidemiologyExposure toFluorineFoodFundingFutureGoalsGrantGuidelinesHalf-LifeHealthHumanHuman MilkHypothyroidismIndividualInfantInfant formulaK-Series Research Career ProgramsKnowledgeLeadershipLengthLifeLinkLow Birth Weight InfantMeasuresMentored Research Scientist Development AwardMentorsMetabolicMethodologyMethodsMilkMothersOutcomeOutcome StudyPerinatalPhasePlacentaPoly-fluoroalkyl substancesPopulationPre-EclampsiaPredispositionPregnancyProcess AssessmentProductionProductivityPropertyPublic HealthResearchResearch DesignResearch PersonnelRhode IslandRisk AssessmentSamplingSerumSourceStatistical Data InterpretationStructureTechniquesTestingTimeToxic effectToxicity TestsTrainingUmbilical Cord BloodVulnerable Populationsanalytical methodcandidate selectioncareercareer developmentcohortcomputerized data processingcritical periodearly life exposureexperienceexposed human populationinfancyinnovationmanufacturematernal serummembernext generationperfluorooctane sulfonateperfluorooctanoic acidpost pregnancypostnatalpreventprogramsskill acquisitionskillsstatisticssubstance usesymposiumthyroid disruptionvaccine response
项目摘要
Project Summary (Abstract)
Per- and polyfluorinated alkyl substances (PFAS) are a public health concern given their environmental
persistence, long biological half-life in humans, and related health effects. Exposure to PFAS during gestation,
infancy, and childhood is associated with low birth weight, preeclampsia, hypothyroidism, reduced vaccine
response, and metabolic alterations. The phase out of legacy PFAS, most prominently perfluorooctanoic acid
and (PFOA) and perfluorooctane sulfonate (PFOS), has led to increased manufacturing of understudied PFAS,
which contain shorter C-F chain lengths or branched structures. However, limited information is available
regarding the extent of exposure and toxicity of these understudied PFAS. Thus, there is a critical need to
understand the contribution of understudied, or replacement, PFAS to total PFAS exposure. This proposal will
fill gaps in our knowledge of human exposure to understudied PFAS during developmentally sensitive periods
of life using a combination of targeted and untargeted analytical methods in two cohorts. The central hypothesis
will be tested and our overall objectives will be accomplished by pursuing two specific aims: (1) Characterize the
relations of EOF, legacy PFAS, and understudied PFAS within and between maternal serum, placenta, and cord
blood samples and (2) Quantify EOF, legacy PFAS, and understudied PFAS levels in breastmilk and formula
and determine their contribution to infant serum EOF, legacy PFAS and understudied PFAS levels.
Characterizing the magnitude of exposure to understudied, replacement PFAS is a critical need in the risk
assessment process and will help guide future studies in the selection of candidate PFAS to examine.
Furthermore, understanding how milk and formula contribute to infant PFAS body burden can help inform
breastfeeding guidance in exposed populations. This career development award will extend the candidate’s prior
training and research experience in environmental engineering and environmental analytical chemistry by
providing expert mentoring and protected time to 1) gain experiential learning in study design for epidemiological
and chemical exposure research, 2) develop expertise in untargeted PFAS analysis, 3) acquire proficiency in
advanced statistical data analysis, and 4) develop professional and leadership skills. Her primary mentor Dr.
Joseph Braun (epidemiology, chemical exposure), along with members of her mentoring team Dr. Krystal Pollitt
(untargeted PFAS analysis) and Dr. Shelley Liu (statistics), will provide the needed mentoring for the candidate
to establish a productive independent research program. This will be achieved through hands-on training that
includes coursework, conferences, grant development, scientific communication, and career development skills.
Upon successful completion of the training portion of this grant, it is expected that Dr. Manz will be successful
as an independent investigator and prepared to establish a R01 funded research program.
项目摘要(摘要)
鉴于其环境
持久性,人类的长生物学半衰期以及相关的健康影响。妊娠期间暴露于PFA,
婴儿期和童年与低出生体重,先兆子痫,甲状腺功能减退,疫苗降低有关
反应和代谢改变。遗产PFA的阶段,最突出的全氟辛酸酸
(PFOA)和全氟辛烷磺酸盐(PFO),导致已知PFA的生产增加,
包含较短的C-F链长或分支结构。但是,有限的信息可用
关于这些理解的PFA的暴露和毒性程度。那是迫切需要的
了解理解或替代PFA对PFA总暴露的贡献。该提议将
填补我们对人类暴露在发展敏感时期中了解PFA的知识的空白
在两个队列中使用靶向和非目标分析方法的组合。中心假设
将经过测试,我们的整体目标将通过追求两个具体目标来实现:(1)表征
EOF的关系,传统PFA和Mater血清,胎盘和绳索之间的PFA
血液样本和(2)量化母乳和配方中的EOF,传统PFA和PFAS水平
并确定它们对婴儿血清EOF,Legacy PFA和PFAS水平的贡献。
替代PFA是特征的幅度,PFA是风险的迫切需求
评估过程,将有助于指导未来的研究候选PFA进行检查。
此外,了解牛奶和配方奶对婴儿PFAS身体的贡献如何有助于告知
裸露人群的母乳喂养指导。该职业发展奖将扩大候选人的先验
通过
提供专家的心理和受保护时间1)获得流行病学研究设计的经验学习经验
和化学暴露研究,2)在未靶向的PFA分析方面发展专业知识,3)熟练程度
高级统计数据分析,以及4)发展专业和领导能力。她的主要导师博士
约瑟夫·布劳恩(Joseph Braun)(流行病学,化学曝光),以及她的指导团队Krystal Pollitt博士
(未靶向的PFA分析)和Shelley Liu博士(统计)将为候选人提供所需的心理
建立独立研究计划。这将通过动手培训来实现
包括课程,会议,赠款发展,科学沟通和职业发展技能。
成功完成了这笔赠款的培训部分后,预计曼兹博士将成功
作为独立研究者,并准备建立R01资助的研究计划。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Katherine Elizabeth Manz其他文献
Katherine Elizabeth Manz的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似国自然基金
时空序列驱动的神经形态视觉目标识别算法研究
- 批准号:61906126
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
本体驱动的地址数据空间语义建模与地址匹配方法
- 批准号:41901325
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
- 批准号:61802133
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
- 批准号:61872252
- 批准年份:2018
- 资助金额:64.0 万元
- 项目类别:面上项目
针对内存攻击对象的内存安全防御技术研究
- 批准号:61802432
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Penn State TCORS: Tobacco Product Composition Effects on Toxicity and Addiction
宾夕法尼亚州立大学 TCORS:烟草产品成分对毒性和成瘾性的影响
- 批准号:
10665895 - 财政年份:2023
- 资助金额:
$ 15.89万 - 项目类别:
Integrative Single-Cell Atlas of Host and Microenvironment in Colorectal Neoplastic Transformation
结直肠肿瘤转化中宿主和微环境的综合单细胞图谱
- 批准号:
10820067 - 财政年份:2023
- 资助金额:
$ 15.89万 - 项目类别:
Structurally engineered furan fatty acids for the treatment of dyslipidemia and cardiovascular disease
结构工程呋喃脂肪酸用于治疗血脂异常和心血管疾病
- 批准号:
10603408 - 财政年份:2023
- 资助金额:
$ 15.89万 - 项目类别:
XVIR-110 an ultra-long-acting INSTI for HIV pre-exposure prophylaxis in IND-enabling studies
XVIR-110 是一种超长效 INSTI,用于 IND 支持研究中的 HIV 暴露前预防
- 批准号:
10764186 - 财政年份:2023
- 资助金额:
$ 15.89万 - 项目类别:
Impact of Exposure to Perfluoroalkyl Substances on Weight Loss: A Pilot Study of Hispanic Children with Overweight/Obesity Participating in a Community-based Weight Loss Intervention Program
接触全氟烷基物质对减肥的影响:对参加社区减肥干预计划的超重/肥胖西班牙裔儿童的初步研究
- 批准号:
10724050 - 财政年份:2023
- 资助金额:
$ 15.89万 - 项目类别: